Home » ACRUX GRANTED FIRST GRANT IN EUROPE, TRIGGERING PAYMENT FROM LILLY
ACRUX GRANTED FIRST GRANT IN EUROPE, TRIGGERING PAYMENT FROM LILLY
Acrux, the Australia-based pharmaceutical company with unique technology for delivering drugs through the skin, today announced that the European Patent Office has granted the key core patent protecting Acrux's drug delivery technology. Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=42788)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May